Koulla-Shiro S - Search Results

1

APOL1 Renal Risk Variants and Kidney Function in HIV-1-Infected People From Sub-Saharan Africa.

Kabore NF, Cournil A, Poda A, Ciaffi L, Binns-Roemer E, David V, Eymard-Duvernay S, Zoungrana J, Semde A, Sawadogo AB, Koulla-Shiro S, Kouanfack C, Ngom-Gueye NF, Meda N, Winkler C, Limou S. Kabore NF, et al. Among authors: koulla shiro s. Kidney Int Rep. 2021 Oct 16;7(3):483-493. doi: 10.1016/j.ekir.2021.10.009. eCollection 2022 Mar. Kidney Int Rep. 2021. PMID: 35257061 Free PMC article.

2

Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.

Boyer S, Nishimwe ML, Sagaon-Teyssier L, March L, Koulla-Shiro S, Bousmah MQ, Toby R, Mpoudi-Etame MP, Ngom Gueye NF, Sawadogo A, Kouanfack C, Ciaffi L, Spire B, Delaporte E; 2-Lady Group. Boyer S, et al. Pharmacoecon Open. 2020 Mar;4(1):45-60. doi: 10.1007/s41669-019-0157-9. Pharmacoecon Open. 2020. PMID: 31273686 Free PMC article.

3

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.

Ciaffi L, Koulla-Shiro S, Sawadogo A, le Moing V, Eymard-Duvernay S, Izard S, Kouanfack C, Ngom Gueye NF, Fobang AA, Reynes J, Calmy A, Delaporte E; 2LADY Study Group. Ciaffi L, et al. AIDS. 2015 Jul 31;29(12):1473-81. doi: 10.1097/QAD.0000000000000709. AIDS. 2015. PMID: 26244387 Free PMC article. Clinical Trial.

4

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.

Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group. Ciaffi L, et al. Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28. Lancet HIV. 2017. PMID: 28566227 Clinical Trial.

5

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.

Kabore FN, Eymard-Duvernay S, Zoungrana J, Badiou S, Bado G, Héma A, Diouf A, Delaporte E, Koulla-Shiro S, Ciaffi L, Cournil A. Kabore FN, et al. PLoS One. 2017 Nov 8;12(11):e0186686. doi: 10.1371/journal.pone.0186686. eCollection 2017. PLoS One. 2017. PMID: 29117238 Free PMC article. Clinical Trial.

6

Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.

Galy A, Ciaffi L, Le Moing V, Eymard-Duvernay S, Abessolo H, Toby R, Ayangma L, Le Gac S, Mpoudi-Etame M, Koulla-Shiro S, Delaporte E, Cournil A; 2LADY Study Group. Galy A, et al. Antivir Ther. 2016;21(6):547-552. doi: 10.3851/IMP3030. Epub 2016 Feb 16. Antivir Ther. 2016. PMID: 26882335 Clinical Trial.

7

Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trial.

Cournil A, Hema A, Eymard-Duvernay S, Ciaffi L, Badiou S, Kabore FN, Diouf A, Ayangma L, Le Moing V, Reynes J, Koulla-Shiro S, Delaporte E; 2LADY Study Group. Cournil A, et al. Antivir Ther. 2017;22(3):195-203. doi: 10.3851/IMP3097. Epub 2016 Oct 5. Antivir Ther. 2017. PMID: 27705950

8

Getting pregnant in HIV clinical trials: women's choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials.

Serris A, Zoungrana J, Diallo M, Toby R, Mpoudi Ngolle M, Le Gac S, Coutherut J, Cournil A, De Beaudrap P, Koulla-Shiro S, Delaporte E, Ciaffi L. Serris A, et al. HIV Clin Trials. 2016 Nov;17(6):233-241. doi: 10.1080/15284336.2016.1248624. Epub 2016 Nov 1. HIV Clin Trials. 2016. PMID: 27801628

9

Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).

Delaugerre C, Nere ML, Eymard-Duvernay S, Armero A, Ciaffi L, Koulla-Shiro S, Sawadogo A, Ngom Gueye NF, Ndour CT, Mpoudi Ngolle M, Amara A, Chaix ML, Reynes J; ANRS 12286/MOBIDIP study group. Delaugerre C, et al. Among authors: koulla shiro s. J Antimicrob Chemother. 2021 Apr 13;76(5):1286-1293. doi: 10.1093/jac/dkab002. J Antimicrob Chemother. 2021. PMID: 33624081

10

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.

Mbougua JB, Laurent C, Kouanfack C, Bourgeois A, Ciaffi L, Calmy A, Gwet H, Koulla-Shiro S, Ducos J, Mpoudi-Ngolé E, Molinari N, Delaporte E. Mbougua JB, et al. BMC Public Health. 2010 Mar 1;10:105. doi: 10.1186/1471-2458-10-105. BMC Public Health. 2010. PMID: 20193053 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters